Table of Content

Executive Summary
1 Market Overview
1.1 Introduction
1.2 Evolution
1.3 Legalization of Cannabis
1.4 Global Cannabis Market: Key Insights
1.5 North America Cannabis Market
1.5.1 Assumptions and Limitations

2 Market Dynamics
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Rising Demand and Increasing Legalization of Cannabis
2.3.2 Ease of Availability of Cannabis Plant
2.3.3 Wide Range of Benefits for both Medical and Recreational Use
2.4 Market Challenges
2.4.1 Stringent Regulation and Lengthy Approval Process
2.4.2 Side Effects Associated with Cannabis Consumption
2.4.3 High Cost and Complex Distribution Channel
2.5 Market Opportunities
2.5.1 Continuing Research for Development of Safer Forms of Cannabis
2.5.2 Shifting Trend of Cannabis Industry Toward Online Platform

3 Competitive Landscape
3.1 Overview
3.1.1 Collaborations, and Partnerships
3.1.2 Mergers and Acquisitions
3.1.3 Business Expansion
3.1.4 Product Launches
3.1.5 Awards and Recognitions

4 Industry Insights
4.1 Canada Legal Landscape
4.1.1 Cannabis Framework and Legislation by Provinces and Territories
4.1.1.1 Alberta
4.1.1.2 British Colombia
4.1.1.3 Manitoba
4.1.1.4 Newfoundland and Labrador
4.1.1.5 Northwest Territories
4.1.1.6 New Brunswick
4.1.1.7 Nova Scotia
4.1.1.8 Nunavut
4.1.1.9 Ontario
4.1.1.10 Qu?bec
4.1.1.11 Saskatchewan
4.1.1.12 Prince Edward Island
4.1.1.13 Yukon
4.2 U.S. Legal Landscape
4.2.1 U.S. Federal Laws Impacting Cannabis Market
4.2.2 U.S. State Laws Impacting Cannabis Market
4.2.3 Medical Cannabis Laws
4.2.3.1 CBD/Limited Laws
4.2.3.2 Recreational Laws

5 North America Cannabis Market (by Product)
5.1 Overview
5.2 Recreational Cannabis
5.3 Medical Cannabis
5.3.1 Overview
5.3.2 Pain Management
5.3.3 Muscle Spasm
5.3.4 Headache
5.3.5 Anxiety
5.3.6 Nausea and Vomiting
5.3.7 Other Medical Applications

6 North America Cannabis Market (by Distribution Channel)
6.1 Overview

7 North America Cannabis Market (by Country)
7.1 Introduction
7.1.1 The U.S.
7.1.1.1 The U.S. Cannabis Market (by Product), 2018-2025
7.1.1.2 The U.S. Cannabis Market (by Medical Application), 2018-2025
7.1.1.3 The U.S. Cannabis Market (by Product Category), 2018-2025
7.1.1.4 The U.S. Cannabis Market (by Distribution Channel), 2018-2025
7.1.2 Canada
7.1.2.1 Canada Cannabis Market (by Product), 2018-2025
7.1.2.2 Canada Cannabis Market (by Medical Application), 2018-2025
7.1.2.3 Canada Cannabis Market (by Distribution Channel), 2018-2025

8 Company Profile
8.1 Competitive Dashboard
8.2 Aphria, Inc.
8.2.1 Company Overview
8.2.2 Company Description
8.2.3 Financials
8.2.4 SWOT Analysis
8.3 Aurora Cannabis Inc.
8.3.1 Company Overview
8.3.2 Company Description
8.3.3 Financials
8.3.4 SWOT Analysis
8.4 Canopy Growth Corporation
8.4.1 Company Overview
8.4.2 Company Description
8.4.3 Financials
8.4.4 SWOT Analysis
8.5 CannTrust Holdings Inc.
8.5.1 Company Overview
8.5.2 Company Description
8.5.3 Financials
8.5.4 SWOT Analysis
8.6 Cronos Group Inc.
8.6.1 Company Overview
8.6.2 Company Description
8.6.3 Financials
8.6.4 SWOT Analysis
8.7 Curaleaf Holdings, Inc.
8.7.1 Company Overview
8.7.2 Company Description
8.7.3 Financials
8.7.4 SWOT Analysis
8.8 Cresco Labs, Inc.
8.8.1 Company Overview
8.8.2 Company Description
8.8.3 Financials
8.8.4 SWOT Analysis
8.9 Terra Tech Corp.
8.9.1 Company Overview
8.9.2 Company Description
8.9.3 Financials
8.9.4 SWOT Analysis
8.10 Tilray, Inc.
8.10.1 Company Overview
8.10.2 Company Description
8.10.3 Financials
8.10.4 SWOT Analysis
8.11 Trulieve Cannabis Corp.
8.11.1 Company Overview
8.11.2 Company Description
8.11.3 Financials
8.11.4 SWOT Analysis

9 Research Scope and Methodology
9.1 Research Scope
9.2 North America Cannabis Market: Research Methodology



List of Tables



Table 2.1: Impact Analysis of Market Drivers
Table 2.2: Impact Analysis of Market Challenges
Table 2.3: Price of cannabis per gram and tax structure for countries of the U.S. and Canada
Table 4.1: Key Regulations, by Canadian Provinces and Territories
Table 4.2: List of States (U.S.) that have Legalized Cannabis for Medical Purposes
Table 4.3: Key Regulations, by U.S. States for Medical Cannabis
Table 8.1: Aphria, Inc.: Key Financials, 2016-2018
Table 8.2: Aphria, Inc.: Operating Expenses, 2016-2018
Table 8.3: Aphria, Inc.: Cost related to Inventory, 2016-2018
Table 8.4: Aurora Cannabis Inc.: Segmental Revenue, 2017-2018
Table 8.5: Aurora Cannabis Inc.: Key Financials, 2016-2018
Table 8.6: Aurora Cannabis Inc.: Operating Expenses, 2016-2018
Table 8.7: Aurora Cannabis Inc.: Cost related to Inventory, 2016-2018
Table 8.8: Canopy Growth Corporation: Key Financials, 2016-2018
Table 8.9: Canopy Growth Corporation: Operating Expenses, 2016-2018
Table 8.10: Canopy Growth Corporation: Cost related to Inventory, 2017-2018
Table 8.11: CannTrust Holdings Inc.: Segmental Revenue, 2017-2018
Table 8.12: CannTrust Holdings Inc.: Key Financials, 2016-2018
Table 8.13: CannTrust Holdings Inc.: Operating Expenses, 2016-2018
Table 8.14: CannTrust Holdings Inc.: Cost related to Inventory, 2017-2018
Table 8.15: Cronos Group Inc.: Segmental Revenue, 2017-2018
Table 8.16: Cronos Group Inc.: Key Financials, 2016-2018
Table 8.17: Cronos Group Inc.: Operating Expenses, 2016-2018
Table 8.18: Cronos Group Inc.: Cost related to Inventory, 2017-2018
Table 8.19: Curaleaf Holdings, Inc.: Segmental Revenue, 2017-2018
Table 8.20: Curaleaf Holdings, Inc.: Key Financials, 2017-2018
Table 8.21: Curaleaf Holdings, Inc.: Operating Expenses, 2017-2018
Table 8.22: Curaleaf Holdings, Inc.: Cost related to Inventory, 2017-2018
Table 8.23: Cresco Labs, Inc.: Key Financials, 2016-2018
Table 8.24: Cresco Labs, Inc.: Operating Expenses, 2017-2018
Table 8.25: Terra Tech Corp.: Segmental Revenue, 2016-2018
Table 8.26: Terra Tech Corp.: Key Financials, 2016-2018
Table 8.27: Terra Tech Corp.: Operating Expenses, 2017-2018
Table 8.28: Terra Tech Corp.: Cost related to Inventory, 2016-2018
Table 8.29: Tilray, Inc.: Segmental Revenue, 2016-2018
Table 8.30: Tilray, Inc.: Regional Revenue, 2016-2018
Table 8.31: Tilray, Inc.: Key Financials, 2016-2018
Table 8.32: Tilray, Inc.: Operating Expenses, 2016-2018
Table 8.33: Tilray, Inc.: Cost related to Inventory, 2017-2018
Table 8.34: Trulieve Cannabis Corp.: Key Financials, 2017-2018
Table 8.35: Trulieve Cannabis Corp.: Operating Expenses, 2017-2018
Table 8.36: Trulieve Cannabis Corp.: Cost related to Inventory, 2017-2018

List of Figures



Figure 1: North America Cannabis Market Scenario (by Country), 2018-2025
Figure 2: Impact of Market Dynamics, 2018
Figure 3: Share of Key Developments and Strategies, January 2015 to March 2019
Figure 4: North America Cannabis Market Share (by Product Type), 2018 and 2025
Figure 5: North America Cannabis Market Share (by Medical Application), 2018 and 2025
Figure 6: North America Cannabis Market Share (by Distribution Channel), 2018 and 2029
Figure 1.1: North America Cannabis Market, 2018-2025
Figure 2.1: Market Dynamics
Figure 3.1: Share of Key Developments and Strategies, January 2017-April 2019
Figure 3.2: Collaborations, and Partnerships (by Companies), January 2017-April 2019
Figure 3.3: Mergers and Acquisitions (by Companies), January 2017-April 2019
Figure 3.4: Business Expansion (by Companies), January 2017-April 2019
Figure 3.5: Product Launches (by Companies), January 2017-April 2019
Figure 3.6: Awards and Recognitions (by Companies), January 2017-April 2019
Figure 4.1: Timeline: Legalization of Cannabis in Canada
Figure 4.2: Timeline: Legalization of Cannabis in the U.S.
Figure 4.3: Federal Laws Impacting U.S. Cannabis Market
Figure 5.1: North America Cannabis Market Segmentation (by Product Type)
Figure 5.2: North America Cannabis Market (by Product)
Figure 5.3: North America Cannabis Market (Recreational Cannabis), 2018-2025
Figure 5.4: North America Cannabis Market (Medical Cannabis), 2018-2025
Figure 5.5: North America Cannabis Market Segmentation (by Medical Application)
Figure 5.6: North America Cannabis Market, by Medical Application
Figure 5.7: North America Cannabis Market (by Medical Application for Pain Management), 2018-2025
Figure 5.8: North America Cannabis Market (Medical Application for Muscle Spasm), 2018-2025
Figure 5.9: North America Cannabis Market (by Medical Application for Muscle Spasm), 2018-2025
Figure 5.10: North America Cannabis Market (by Medical Application for Anxiety), 2018-2025
Figure 5.11: North America Cannabis Market (by Medical Application for Nausea and Vomiting), 2018-2025
Figure 5.12: North America Cannabis Market (by Medical Application for Others) 2018-2025
Figure 6.1: North America Cannabis Market Supply Chain
Figure 6.2: North America Cannabis Market (by Distribution Channel), 2018-2015
Figure 7.1: North America Cannabis Market (by Country), 2018-2025
Figure 7.2: The U.S. Cannabis Market, 2018-2025
Figure 7.3: The U.S. Cannabis Market (by Product Type), 2018-2025
Figure 7.4: The U.S. Cannabis Market (by Medical Application), 2018-2025
Figure 7.5: The U.S. Cannabis Market (by Product Category), 2018-2025
Figure 7.6: The U.S. Cannabis Market (by Distribution Channel), 2018-2025
Figure 7.7: Canada Cannabis Market, 2018-2025
Figure 7.8: Canada Cannabis Market (by Product Type), 2018-2025
Figure 7.9: Canada Cannabis Market (by Medical Application), 2018-2025
Figure 7.10: Canada Cannabis Market (by Distribution Channel), 2018-2025
Figure 8.1: Aphria, Inc.: Brand Portfolio
Figure 8.2: Aphria, Inc.: Net Revenue and Y-o-Y, 2016-2018
Figure 8.3: SWOT Analysis: Aphria, Inc.
Figure 8.4: Aurora Cannabis Inc.: Brand Portfolio
Figure 8.5: Aurora Cannabis Inc.: Net Revenue and Y-o-Y, 2016-2018
Figure 8.6: SWOT Analysis: Aurora Cannabis Inc.
Figure 8.7: Canopy Growth Corporation: Brand Portfolio
Figure 8.8: Canopy Growth Corporation: Net Revenue and Y-o-Y, 2016-2018
Figure 8.9: SWOT Analysis: Canopy Growth Corporation
Figure 8.10: CannTrust Holdings Inc.: Brand Portfolio
Figure 8.11: CannTrust Holdings Inc.: Net Revenue and Y-o-Y, 2016-2018
Figure 8.12: SWOT Analysis: CannTrust Holdings Inc.
Figure 8.13: Cronos Group Inc.: Brand Portfolio
Figure 8.14: Cronos Group Inc.: Net Revenue and Y-o-Y, 2016-2018
Figure 8.16: SWOT Analysis: Cronos Group Inc.
Figure 8.17: Curaleaf Holdings, Inc.: Brand Portfolio
Figure 8.18: Curaleaf Holdings, Inc.: Net Revenue and Y-o-Y, 2017-2018
Figure 8.19: SWOT Analysis: Curaleaf Holdings, Inc.
Figure 8.20: Cresco Labs, Inc.: Brand Portfolio
Figure 8.21: Cresco Labs, Inc.: Net Revenue and Y-o-Y, 2016-2018
Figure 8.22: SWOT Analysis: Cresco Labs, Inc.
Figure 8.23: Terra Tech Corp.: Brand Portfolio
Figure 8.24: Terra Tech Corp.: Net Revenue and Y-o-Y, 2016-2018
Figure 8.25: SWOT Analysis: Terra Tech Corp.
Figure 8.26: Tilray, Inc.: Brand Portfolio
Figure 8.27: Tilray, Inc.: Net Revenue and Y-o-Y, 2016-2018
Figure 8.28: SWOT Analysis: Tilray, Inc.
Figure 8.29: Trulieve Cannabis Corp.: Product Portfolio
Figure 8.30: Trulieve Cannabis Corp.: Net Revenue and Y-o-Y, 2017-2020E
Figure 8.31: SWOT Analysis: Trulieve Cannabis Corp.
Figure 9.1: North America Cannabis Market Segmentation
Figure 9.2: North America Cannabis Market Research Methodology
Figure 9.3: Primary Research
Figure 9.4: Secondary Research
Figure 9.5: Data Triangulation
Figure 9.6: Bottom-up Approach (Segment-wise Analysis)
Figure 9.7: Top-down Approach (Segment-Wise Analysis)
Figure 9.8: Assumptions and Limitations
Figure 9.9: Considered Factors for Data Prediction and Modeling